{"nct_id":"NCT05673785","title":"A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2023-02-10","start_date_type":"ACTUAL","primary_completion_date":"2025-04-27","primary_completion_date_type":"ACTUAL","completion_date":"2027-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["TAK"]}